Balyasny Asset Management
SRRA

Balyasny Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Balyasny Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-210,923
Closed -$11.6M – 3480
2022
Q2 		$11.6M Buy
+210,923
New +$11.1M 0.04% 605

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Balyasny Asset Management's SRRA Position: Q3 2022 in Review

Balyasny Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 210,923 shares — an estimated $11.6M sold.

Balyasny Asset Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $11.6M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Balyasny Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 210,923 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $11.6M.
  • Balyasny Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Balyasny Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $11.6M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.